Segment disclosures

Company overview

RIGEL PHARMACEUTICALS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 24 retained observations 13 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

One Operating Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rigl:OneOperatingSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3080890000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30218411000 USD20261105Open filing evidence
2026-04-01 – 2026-06-3078703000 USD20260804Open filing evidence
2026-01-01 – 2026-06-30137521000 USD20260804Open filing evidence
2026-01-01 – 2026-03-3158818000 USD20260505Open filing evidence
2025-07-01 – 2025-09-3069462000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30224480000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30101685000 USD20260804Open filing evidence
2025-01-01 – 2025-06-30155018000 USD20260804Open filing evidence
2025-01-01 – 2025-03-3153333000 USD20260505Open filing evidence

Single Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rigl:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31294282000 USD20260303Open filing evidence
2025-07-01 – 2025-09-3069462000 USD20251104Open filing evidence
2025-01-01 – 2025-09-30224480000 USD20251104Open filing evidence
2025-04-01 – 2025-06-30101685000 USD20250805Open filing evidence
2025-01-01 – 2025-06-30155018000 USD20250805Open filing evidence
2025-01-01 – 2025-03-3153333000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31179278000 USD20260303Open filing evidence
2024-07-01 – 2024-09-3055307000 USD20251104Open filing evidence
2024-01-01 – 2024-09-30121682000 USD20251104Open filing evidence
2024-04-01 – 2024-06-3036841000 USD20250805Open filing evidence
2024-01-01 – 2024-06-3066375000 USD20250805Open filing evidence
2024-01-01 – 2024-03-3129534000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31116882000 USD20260303Open filing evidence
2022-01-01 – 2022-12-31120242000 USD20250304Open filing evidence